Journey Medical Corporation

Close-up of a woman's face showing details of rosacea on her skin. Her green eyes and expression convey a sense of calmness despite the skin condition.

Journey Medical's Emrosi Rosacea Treatment Receives FDA Approval

Journey Medical Corporation announced the FDA approval of Emrosi, formerly referred to as DFD-29, for the treatment of inflammatory lesions of rosacea in adults.